![Maggie Flanagan LeFlore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Maggie Flanagan LeFlore
Former positions of Maggie Flanagan LeFlore
Companies | Position | Start | End |
---|---|---|---|
MedImmune Ventures, Inc.
![]() MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Private Equity Investor | 01/06/2007 | 30/03/2010 |
ASTRIA THERAPEUTICS, INC. | Director/Board Member | 23/04/2010 | - |
NKT Therapeutics, Inc.
![]() NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Director/Board Member | 27/11/2009 | - |
Training of Maggie Flanagan LeFlore
University of Kansas | Undergraduate Degree |
Indiana University | Doctorate Degree |
Statistics
International
United States | 6 |
Operational
Director/Board Member | 2 |
Private Equity Investor | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ASTRIA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
MedImmune Ventures, Inc.
![]() MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
NKT Therapeutics, Inc.
![]() NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Health Technology |